Skip to main content
main-content

Tipp

Weitere Artikel dieser Ausgabe durch Wischen aufrufen

Erschienen in: memo - Magazine of European Medical Oncology 1/2020

24.10.2019 | short review

Evidence-based follow-up for breast cancer

Short review

verfasst von: Michael Stierer

Erschienen in: memo - Magazine of European Medical Oncology | Ausgabe 1/2020

Einloggen, um Zugang zu erhalten
share
TEILEN

Summary

A large number of medical societies have issued recommendations for follow-up after primary treatment for early breast cancer, which mostly differ only in the details. The central statement in all of these guidelines has been based on two studies that were published in 1994 and came under criticism due to methodological flaws and the lack of modern diagnostic tools. This statement contains the merely symptom-induced search for distant metastasis and the rejection of routine imaging procedures and biomarker analyses in the follow-up process. Prospective, randomized and optimally designed trials are necessary to re-evaluate this dogma in view of the diagnostic and treatment progress since that time. The prognosis of mono- and oligometastatic disease diagnosed in this connection could lead to long-term survival. Presently, the existing guidelines should be followed accurately. The objectives of follow-up include early detection of local–regional recurrences and contralateral breast cancer, the management of treatment side effects and toxicities, motivation of patients to comply, psychosocial rehabilitation and lifestyle counseling with regard to the improvement of breast cancer prognosis. In conclusion, breast cancer survivors require comprehensive follow-up management based on evidence, whenever possible.
Literatur
1.
Zurück zum Zitat Liu WL, Jansen L, Post WJ, Bonnema J, Van de Velde JC, De Bock GH. Impact on survival of early detection of isolated breast recurrences after the primary treatment for breast cancer: a meta-analysis. Breast Cancer Res Treat. 2009;114(3):403–12. CrossRef Liu WL, Jansen L, Post WJ, Bonnema J, Van de Velde JC, De Bock GH. Impact on survival of early detection of isolated breast recurrences after the primary treatment for breast cancer: a meta-analysis. Breast Cancer Res Treat. 2009;114(3):403–12. CrossRef
2.
Zurück zum Zitat Houssami N, Ciatto S. Mammographic surveillance in women with a personal history of breast cancer: how accurate? How effective? Breast. 2010;19(6):439–45. CrossRef Houssami N, Ciatto S. Mammographic surveillance in women with a personal history of breast cancer: how accurate? How effective? Breast. 2010;19(6):439–45. CrossRef
3.
Zurück zum Zitat GIVIO Investigators. Impact of follow-up testing on survival and health-related quality of life in breast cancer patients: a multicenter randomized controlled trial. JAMA. 1994;271(20):1587–92. CrossRef GIVIO Investigators. Impact of follow-up testing on survival and health-related quality of life in breast cancer patients: a multicenter randomized controlled trial. JAMA. 1994;271(20):1587–92. CrossRef
4.
Zurück zum Zitat Rosselli Del Turco M, Palli D, Cariddi A, Ciatto S, Pacini P, Distante V. Intensive diagnostic follow-up after treatment of primary breast cancer: a randomized trial. JAMA. 1994;271(20):1593–7. CrossRef Rosselli Del Turco M, Palli D, Cariddi A, Ciatto S, Pacini P, Distante V. Intensive diagnostic follow-up after treatment of primary breast cancer: a randomized trial. JAMA. 1994;271(20):1593–7. CrossRef
9.
Zurück zum Zitat Runowicz CD, Leach CR, Henry NL, et al. American Cancer Society/American Society of Clinical Oncology breast cancer survivorship care guideline. J Clin Oncol. 2016;34(6):611–35. CrossRef Runowicz CD, Leach CR, Henry NL, et al. American Cancer Society/American Society of Clinical Oncology breast cancer survivorship care guideline. J Clin Oncol. 2016;34(6):611–35. CrossRef
10.
Zurück zum Zitat Kim SM, Park JM. Normal and abnormal US findings at the mastectomy site. Radiographics. 2004;24(2):357–65. CrossRef Kim SM, Park JM. Normal and abnormal US findings at the mastectomy site. Radiographics. 2004;24(2):357–65. CrossRef
11.
Zurück zum Zitat Rissanen TJ, Mäkäräinen HP, Mattila SI, Lindholm EL, Heikkinen MI, Kiviniemi HO. Breast cancer recurrence after mastectomy: diagnosis with mammography and ultrasound. Radiology. 1993;188(2):463–7. CrossRef Rissanen TJ, Mäkäräinen HP, Mattila SI, Lindholm EL, Heikkinen MI, Kiviniemi HO. Breast cancer recurrence after mastectomy: diagnosis with mammography and ultrasound. Radiology. 1993;188(2):463–7. CrossRef
12.
Zurück zum Zitat Saslow D, Boetes C, Burke W, et al. American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin. 2007;57(2):75–89. CrossRef Saslow D, Boetes C, Burke W, et al. American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin. 2007;57(2):75–89. CrossRef
13.
Zurück zum Zitat Papassotiropoulos B, Güth U, Chiesa F, et al. Prospective evaluation of residual breast tissue after skin- or nipple-sparing mastectomy: results of the SKINI-Trial. Ann Surg Oncol. 2019;26(5):1254–62. CrossRef Papassotiropoulos B, Güth U, Chiesa F, et al. Prospective evaluation of residual breast tissue after skin- or nipple-sparing mastectomy: results of the SKINI-Trial. Ann Surg Oncol. 2019;26(5):1254–62. CrossRef
14.
Zurück zum Zitat Boné B, Aspelin P, Isberg B, Perbeck L, Veress B. Contrast-enhanced MR imaging of the breast in patients with breast implants after cancer surgery. Acta radiol. 1995;36(2):111–6. CrossRef Boné B, Aspelin P, Isberg B, Perbeck L, Veress B. Contrast-enhanced MR imaging of the breast in patients with breast implants after cancer surgery. Acta radiol. 1995;36(2):111–6. CrossRef
15.
Zurück zum Zitat Thomas DB, Gao DL, Ray RM, et al. Randomized trial of breast self-examination in Shanghai: final results. J Natl Cancer Inst. 2002;94(19):1445–57. CrossRef Thomas DB, Gao DL, Ray RM, et al. Randomized trial of breast self-examination in Shanghai: final results. J Natl Cancer Inst. 2002;94(19):1445–57. CrossRef
16.
Zurück zum Zitat Smith RA, Manassaram-Baptiste D, Brooks D, et al. Cancer screening in the United States, 2015: a review of current American Cancer Society Guidelines and current issues in cancer screening. CA Cancer J Clin. 2015;65(1):30–54. CrossRef Smith RA, Manassaram-Baptiste D, Brooks D, et al. Cancer screening in the United States, 2015: a review of current American Cancer Society Guidelines and current issues in cancer screening. CA Cancer J Clin. 2015;65(1):30–54. CrossRef
17.
Zurück zum Zitat Pan H, Gray R, Braybrooke J, et al. 20-year risks of breast cancer recurrence after stopping endocrine therapy at 5 years. N Engl J Med. 2017;377(19):1836–46. CrossRef Pan H, Gray R, Braybrooke J, et al. 20-year risks of breast cancer recurrence after stopping endocrine therapy at 5 years. N Engl J Med. 2017;377(19):1836–46. CrossRef
18.
Zurück zum Zitat Ribelles N, Perez-Villa L, Jerez JM, et al. Pattern of recurrence of early breast cancer is different according to intrinsic subtype and proliferation index. Breast Cancer Res. 2013;15(5):R98. CrossRef Ribelles N, Perez-Villa L, Jerez JM, et al. Pattern of recurrence of early breast cancer is different according to intrinsic subtype and proliferation index. Breast Cancer Res. 2013;15(5):R98. CrossRef
19.
Zurück zum Zitat Chlebowski RT, Aiello E, McTiernan A. Weight loss in breast cancer patient management. J Clin Oncol. 2002;20(4):1128–43. CrossRef Chlebowski RT, Aiello E, McTiernan A. Weight loss in breast cancer patient management. J Clin Oncol. 2002;20(4):1128–43. CrossRef
20.
Zurück zum Zitat Vrieling A, Buck K, Seibold P, et al. Dietary patterns and survival in German postmenopausal breast cancer survivors. Br J Cancer. 2013;108(1):188–92. CrossRef Vrieling A, Buck K, Seibold P, et al. Dietary patterns and survival in German postmenopausal breast cancer survivors. Br J Cancer. 2013;108(1):188–92. CrossRef
21.
Zurück zum Zitat Bérubé S, Lemieux J, Moore L, Maunsell E, Brisson J. Smoking at time of diagnosis and breast cancer-specific survival: new findings and systematic review with meta-analysis. Breast Cancer Res. 2014;16(2):R42. CrossRef Bérubé S, Lemieux J, Moore L, Maunsell E, Brisson J. Smoking at time of diagnosis and breast cancer-specific survival: new findings and systematic review with meta-analysis. Breast Cancer Res. 2014;16(2):R42. CrossRef
22.
Zurück zum Zitat US Preventive Services Task Force. Screening for osteoporosis to prevent fractures. US Preventive Services Task Force recommendation statement. JAMA. 2018;319(24):2521–31. CrossRef US Preventive Services Task Force. Screening for osteoporosis to prevent fractures. US Preventive Services Task Force recommendation statement. JAMA. 2018;319(24):2521–31. CrossRef
23.
Zurück zum Zitat Gralow JR, Biermann JS, Farooki A, et al. NCCN Task Force Report: bone health in cancer care. J Natl Compr Canc Netw. 2013;11(suppl 3):S1–S50. CrossRef Gralow JR, Biermann JS, Farooki A, et al. NCCN Task Force Report: bone health in cancer care. J Natl Compr Canc Netw. 2013;11(suppl 3):S1–S50. CrossRef
24.
Zurück zum Zitat Darby SC, Ewertz M, McGale P, et al. Risk of ischemic heart disease in women after radiotherapy for breast cancer. N Engl J Med. 2013;368(11):987–98. CrossRef Darby SC, Ewertz M, McGale P, et al. Risk of ischemic heart disease in women after radiotherapy for breast cancer. N Engl J Med. 2013;368(11):987–98. CrossRef
25.
Zurück zum Zitat Curigliano G, Cardinale D, Suter T, et al. Cardiovascular toxicity induced by chemotherapy, targeted agents and radiotherapy. ESMO Clinical Practice Guidelines. Ann Oncol. 2012;23(suppl 7):vii155–vii66. CrossRef Curigliano G, Cardinale D, Suter T, et al. Cardiovascular toxicity induced by chemotherapy, targeted agents and radiotherapy. ESMO Clinical Practice Guidelines. Ann Oncol. 2012;23(suppl 7):vii155–vii66. CrossRef
26.
Zurück zum Zitat Hernberg M, Virkkunen P, Maasilta P, et al. Pulmonary toxicity after radiotherapy in primary breast cancer patients: results from a randomized chemotherapy study. Int J Radiat Oncol Biol Phys. 2002;52(1):128–36. CrossRef Hernberg M, Virkkunen P, Maasilta P, et al. Pulmonary toxicity after radiotherapy in primary breast cancer patients: results from a randomized chemotherapy study. Int J Radiat Oncol Biol Phys. 2002;52(1):128–36. CrossRef
27.
Zurück zum Zitat Witteveen A, Otten JWM, Vliegen IMH, Siesling S, Timmer JB, IJzerman MJ. Risk-based breast cancer follow-up stratified by age. Cancer Med. 2018;7(10):5291–8. CrossRef Witteveen A, Otten JWM, Vliegen IMH, Siesling S, Timmer JB, IJzerman MJ. Risk-based breast cancer follow-up stratified by age. Cancer Med. 2018;7(10):5291–8. CrossRef
28.
Zurück zum Zitat Hortobagyi GN. Can we cure limited metastatic breast cancer? J Clin Oncol. 2002;20(3):620–3. CrossRef Hortobagyi GN. Can we cure limited metastatic breast cancer? J Clin Oncol. 2002;20(3):620–3. CrossRef
Metadaten
Titel
Evidence-based follow-up for breast cancer
Short review
verfasst von
Michael Stierer
Publikationsdatum
24.10.2019
Verlag
Springer Vienna
Erschienen in
memo - Magazine of European Medical Oncology / Ausgabe 1/2020
Print ISSN: 1865-5041
Elektronische ISSN: 1865-5076
DOI
https://doi.org/10.1007/s12254-019-00531-w